FDA Inspection 1155218 — Arbor Pharmaceuticals Inc.
The FDA completed an inspection of Arbor Pharmaceuticals Inc. on Oct 15, 2021 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 15, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Atlanta, GA (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)